109 Zina Pitcher Pl, 4021 BSRB
Ann Arbor, Michgan 48109-2200
Available to mentor
Dr. Callaghan is a Professor of Neurology and a neuromuscular specialist at the University of Michigan. He completed his medical degree and neurology residency at the University of Pennsylvania and completed a fellowship in neuromuscular disease at the University of Michigan. He also completed a master’s degree program in clinical research at the University of Michigan School of Public Health.
-
FellowshipCenter for Healthcare Research and Transformation Policy, University of Michigan, Ann Arbor, Michigan, 2016
-
FellowshipUniversity of Michigan Health System, Neuromuscular, 2009
-
ResidencyUniversity of Pennsylvania Medical Center, Neurology, 2008
-
Internship, Preliminary MedicineUniversity of Pennsylvania Medical Center, Philadelphia, Pennsylvania, 2005
-
MSUniversity of Michigan, Ann Arbor, 2011
-
MDUniversity of Pennsylvania Medical Center, 3400 Spruce Street, 2004
-
BSUniversity of Michigan, Ann Arbor, 1999
-
Center MemberCaswell Diabetes Institute
-
Center MemberInstitute for Healthcare Policy and Innovation
Dr. Callaghan is interested in the treatment of painful diabetic neuropathy and other chronic pain conditions including the role of opioids. He has led the recent American Academy of Neurology guideline on the treatment of painful diabetic neuropathy and is interested in better understanding the best interventions for this common condition. Furthermore, Dr. Callaghan is interested in a better understanding of the appropriate role of opioids in chronic non cancer pain conditions.
-
Reynolds EL, Watanabe M, Banerjee M, Chant E, Villegas-Umana E, Elafros MA, Gardner TW, Pop-Busui R, Pennathur S, Feldman EL, Callaghan BC. Diabetologia, 2023 Jul; 66 (7): 1192 - 1207.Journal ArticleThe effect of surgical weight loss on diabetes complications in individuals with class II/III obesity.
DOI:10.1007/s00125-023-05899-3 PMID: 36917280 -
Merino JG, Ciccarelli O, Barkhof F, Burch R, Callaghan BC, Hedera P, Hershey LA, Jobst BC, Christman Schneider AL, Worrall BB, Wusthoff CJ. Neurology, 2024 Dec 10; 104 (1):Journal ArticleMessage From the Editors to Our Reviewers
DOI:10.1212/WNL.0000000000210282 -
Reynolds EL, Koenig F, Watanabe M, Kwiatek A, Elafros MA, Stino A, Henderson D, Herrmann DN, Feldman EL, Callaghan BC. Ann Clin Transl Neurol, 2024 Dec; 11 (12): 3115 - 3124.Journal ArticleComparison of intraepidermal nerve fiber density and confocal corneal microscopy for neuropathy.
DOI:10.1002/acn3.52218 PMID: 39394845 -
Stino AM, Reynolds EL, Watanabe M, Callaghan BC. Muscle Nerve, 2024 Dec; 70 (6): 1192 - 1199.Journal ArticleIntravenous immunoglobulin and plasma exchange prescribing patterns for Guillain-Barre Syndrome in the United States-2001 to 2018.
DOI:10.1002/mus.28265 PMID: 39324188 -
Gusovsky AV, Lin CC, Kerber K, Reynolds EL, Callaghan BC, Burke JF. Neurology, 2024 Nov 26; 103 (10): e210029Journal ArticleCosts Are Still on the Rise for Commonly Prescribed Branded Neurologic Medications.
DOI:10.1212/WNL.0000000000210029 PMID: 39475685 -
Expert Panel on Neurological Imaging , Shah VN, Parsons MS, Boulter DJ, Burns J, Callaghan B, Eldaya R, Hanak M, Hassankhani A, Hutchins TA, Jackson CD, Khan MA, Mullin J, Ortiz AO, Reitman C, Sampson C, Sandstrom CK, Timpone VM, Trout AT, Policeni B. J Am Coll Radiol, 2024 Nov; 21 (11S): S504 - S517.Journal ArticleACR Appropriateness Criteria® Thoracic Back Pain.
DOI:10.1016/j.jacr.2024.08.016 PMID: 39488357 -
Elafros MA, Reynolds EL, Callaghan BC. Curr Opin Neurol, 2024 Oct 1; 37 (5): 467 - 477.Journal ArticleObesity-related neuropathy: the new epidemic.
DOI:10.1097/WCO.0000000000001292 PMID: 38864534 -
Suresh S, Watanabe M, Reynolds EL, Callaghan BC. Muscle Nerve, 2024 Oct; 70 (4): 791 - 799.Journal ArticlePossible sex and racial disparities in myasthenia gravis care.
DOI:10.1002/mus.28215 PMID: 39072773